Background: Despite the abundant research on financial conflict of interest regarding
provider behaviour and the interpretation and results of research, little is known about the …

Purpose Little is known about the effects of financial relationships between biomedical
researchers and industry (financial conflicts of interest [FCOIs]) on research prominence. We …

Prior studies have shown that financial relationships between editorialists and the
biopharmaceutical industry are associated with increased likelihood of favorable …

Background Transparency in reporting of conflict of interest is an increasingly important
aspect of publication in medical journals. Publication of large industry-supported trials may …

Journal editors are gatekeepers of knowledge, and pharmaceutical industry payments to
oncology editors have not been previously characterized. We performed a cross‐sectional …

These leading medical figures are among dozens of doctors who have failed in recent years
to report their financial relationships with pharmaceutical and health care companies when …

Purpose To test the hypothesis that authors who play key scientific roles in oncology clinical
trials, and who therefore have increased influence over the design, analysis, interpretation …

Background: Editorials accompanying the publication of trials in major oncology journals
can have a substantial influence on clinical practice. We describe the prevalence of financial …

Financial ties between drug companies and medical researchers are thought to bias studies
published in medical journals. To enable readers to account for such bias, most medical …

Abstract The International Committee of Medical Journal Editors requires authors to disclose
all financial conflicts of interest (COI) that can be perceived as influencing the related trials …